David I. Brown

Mr. Brown’s representative work includes advising:

• Nordic Capital in its £2.25 billion sale of The Binding Site, a global leader in specialty diagnostics, to Thermo Fisher Scientific
• The Carlyle Group and Ortho Clinical Diagnostics, a UK-organized, Nasdaq-listed global leader in in vitro diagnostics, in Ortho's merger with Quidel, valuing Ortho at approximately US$6.0 billion
• Nordic Capital in its investment in Equashield, an Israeli-based, leading global provider of closed system transfer devices
• Platinum Equity in its US$2.5 billion acquisition, and subsequent sale, of Multi-Color, a provider of label solutions with business interests in the North America, Latin America, Europe, Middle East, Africa, and Asia
• Platinum Equity in its joint venture with Ball Corp. and acquisition of Ball Corp.’s tinplate food and aerosol packaging businesses, and the eventual sale of this business
• The Carlyle Group in its acquisition and subsequent sale of Workforce Logiq, a leading global provider of workforce management software and services
• Platinum Equity in its acquisition of a controlling stake in SVP-Singer Holdings, Inc., the world’s largest consumer sewing machine company
• Nesco Holdings in its acquisition of Custom Truck One Source, a provider of specialized truck and heavy equipment solutions
• X-Chem, Inc., the industry-leading provider of DNA-Encoded Library-based discovery services, and its stockholders, The Carlyle Group and Hellman & Friedman, in X-Chem’s sale to GHO Capital
• Platinum Equity in its US$3.85 billion acquisition of Husky Injection Molding Systems, a leading supplier of injection molding equipment and services to the global plastics industry
• Platinum Equity in its public-to-private acquisition of Nasdaq-listed Electro Rent, a provider of new and used electronic test and measurement equipment and personal computer rentals, and the subsequent add-on acquisition of UK-based Microlease
• The Carlyle Group in its minority investment in Ion Investment Group, an Ireland-domiciled developer of electric flow trading, commodity, treasury, and risk management solutions
• Pharmaceutical Product Development, a leading global contract research organization, in a number of transactions
• The Carlyle Group in its US$4.15 billion acquisition from Johnson & Johnson of Ortho-Clinical Diagnostics, a global provider of solutions for screening and confirming diseases
• The Carlyle Group in its US$350 million preferred stock investment in Genesee & Wyoming, the largest US short-line railroad operator, in connection with G&W’s US$1.4 billion acquisition of rival, RailAmerica
• Platinum Equity in its acquisition of a recreational and fishing boat business sold by Genmar Holdings in a 363 sale, the subsequent add-on acquisition of Brunswick Corporation’s Triton Boats, and ultimate sale of the recreational boat business to Beneteau Group and the fishing boat business to BassPro
• Booz Allen Hamilton in the US$2.54 billion sale of its government consulting business to The Carlyle Group, and the spin-off of Booz Allen’s commercial consulting business to its partners
• Koch Industries in numerous transactions, including its US$4.4 billion acquisition of INVISTA, DuPont’s former Textiles & Interiors division, and the US$300 million sale of its asphalt products division